Keratosis follicularis spinulosa decalvans
Keratosis Follicularis Spinulosa Decalvans (KFSD) is a rare, X-linked, genodermatosis disorder characterized by keratotic follicular papules, progressive cicatricial alopecia, and associated with eye symptoms. It was first described by Macleod in 1909.
Symptoms and Signs[edit | edit source]
KFSD is characterized by the presence of keratotic follicular papules, progressive cicatricial alopecia, and occasionally associated with photophobia, corneal dystrophy, and other ocular abnormalities. The onset of the disease usually occurs in infancy or early childhood, but late-onset forms of the disease have also been reported.
Causes[edit | edit source]
KFSD is a genetic disorder that is inherited in an X-linked recessive manner. The exact genetic mutation that causes KFSD is currently unknown, but it is believed to involve a defect in the keratinization process of the hair follicle.
Diagnosis[edit | edit source]
The diagnosis of KFSD is primarily based on clinical findings. A skin biopsy may be performed to confirm the diagnosis. Genetic testing may also be useful in confirming the diagnosis and for genetic counseling purposes.
Treatment[edit | edit source]
There is currently no cure for KFSD. Treatment is symptomatic and may include topical keratolytics, retinoids, and emollients. In severe cases, systemic retinoids may be used. Regular follow-up with an ophthalmologist is recommended for those with ocular involvement.
Prognosis[edit | edit source]
The prognosis of KFSD is variable. Some individuals may have mild symptoms and a relatively normal life expectancy, while others may experience severe symptoms and complications such as progressive hair loss and vision loss.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
- National Organization for Rare Disorders (NORD) - Keratosis Follicularis Spinulosa Decalvans
- Genetics Home Reference - Keratosis Follicularis Spinulosa Decalvans
Keratosis follicularis spinulosa decalvans Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD